Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function-Reference-Cited by-同舟云学术

Systemic blockade of ACVR2B ligands attenuates muscle wasting in ischemic heart failure without compromising cardiac function

Published:2020-05-19 Issue:8 Volume:34 Page:9911-9924
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Szabó Zoltán¹,Vainio Laura¹,Lin Ruizhu¹²,Swan Julia¹³,Hulmi Juha J.⁴⁵,Rahtu‐Korpela Lea¹,Serpi Raisa³⁶,Laitinen Mika⁷⁸,Pasternack Arja⁵,Ritvos Olli⁵,Kerkelä Risto¹²,Magga Johanna¹³

Affiliation:

1. Research Unit of Biomedicine Department of Pharmacology and Toxicology University of Oulu Oulu Finland

2. Medical Research Center Oulu Oulu University Hospital and University of Oulu Oulu Finland

3. Biocenter Oulu University of Oulu Oulu Finland

4. Faculty of Sport and Health Sciences Neuromuscular Research Center University of Jyväskylä Jyväskylä Finland

5. Department of Physiology Faculty of Medicine University of Helsinki Helsinki Finland

6. Faculty of Biochemistry and Molecular Medicine University of Oulu Oulu Finland

7. Department of Medicine University of Helsinki Helsinki Finland

8. Department of Medicine Helsinki University Hospital Helsinki Finland

Funder

Academy of Finland

Sydäntutkimussäätiö

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201903074RR

Reference67 articles.

1. Systolic Heart Failure

2. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)

3. Muscle wasting and cachexia in heart failure: mechanisms and therapies

4. Activin A and Follistatin-Like 3 Determine the Susceptibility of Heart to Ischemic Injury

5. Regulation and actions of activin A and follistatin in myocardial ischaemia–reperfusion injury

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of transcriptomics and proteomics for analyzing potential biomarker and molecular mechanism underlying skeletal muscle atrophy;Journal of Proteomics;2024-10

2. Inhibition of activin receptor 2 signalling ameliorates metabolic dysfunction–associated steatotic liver disease in western diet/L-NAME induced cardiometabolic disease;Biomedicine & Pharmacotherapy;2024-06

3. Contribution of VEGF-B-Induced Endocardial Endothelial Cell Lineage in Physiological Versus Pathological Cardiac Hypertrophy;Circulation Research;2024-05-24

4. Urotensin receptor acts as a novel target for ameliorating fasting-induced skeletal muscle atrophy;Pharmacological Research;2022-11

5. Wnt11 in regulation of physiological and pathological cardiac growth;The FASEB Journal;2022-09-13